Poly(amino acid)s: Promising enzymatically degradable stealth coatings for liposomes

International Journal of Pharmaceutics

Volumn 331, Issue 2, 2007, Pages 186-189

  Romberg, Birgit ^a   Metselaar, Josbert M ^a   Baranyi, Lajos ^b   Snel, Cor J ^a   Bünger, Rolf ^c   Hennink, Wim E ^a   Szebeni, Janos ^d   Storm, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Vaccine and Immunology Research Institute   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d US Military HIV Research Program   (United States)

Author keywords

Complement activation; Enzymatic degradability; Long circulating liposomes; Pharmacokinetics; Poly(amino acid) coatings

Indexed keywords

ENDOTOXIN; LIPOSOME; MACROGOL; POLYAMINOACID; POLYHYDROXYETHYL ASPARAGINE; POLYHYDROXYETHYL GLUTAMINE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULATION TIME; COMPLEMENT ACTIVATION; DRUG ACCUMULATION; DRUG COATING; DRUG CONTAMINATION; DRUG FORMULATION; ENZYMATIC DEGRADATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RISK;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; DRUG CARRIERS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; NYLONS; PEPTIDE HYDROLASES; PHARMACOKINETICS; RATS; RATS, WISTAR;

EID: 33846889329     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.11.018     Document Type: Article

References (12)

1. Boomer J.A., Inerowicz H.D., Zhang Z., Bergstrand N., Edwards K., Kim J.M., and Thompson D.H. Acid-triggered release from sterically stabilized fusogenic liposomes via a hydrolytic dePEGylation strategy. Langmuir 19 (2003) 6408-6415
2. Kolb W.P., and Müller-Eberhard H.J. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J. Exp. Med. 141 (1975) 724-735
3. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000) 271-284
4. Metselaar J.M., Bruin P., de Boer L.W., de Vringer T., Snel C., Oussoren C., Wauben M.H., Crommelin D.J., Storm G., and Hennink W.E. A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjug. Chem. 14 (2003) 1156-1164
5. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003) 463-478
6. Prochazkova S., Varum K.M., and Ostgaard K. Quantitative determination of chitosans by ninhydrin. Carbohydr. Polym. 38 (1999) 115-122
7. 5-(2-hydroxyethyl)-l-glutamine-stat-l-glutamic acid]: analysis of final degradation products. J. Bioact. Compat. Polym. 13 (1998) 198-209
8. Romberg B., Metselaar J.M., de Vringer T., Motonaga K., Kettenes-van den Bosch J.J., Oussoren C., Storm G., and Hennink W.E. Enzymatic degradation of liposome-grafted poly(hydroxyethyl l-glutamine). Bioconjug. Chem. 16 (2005) 767-774
9. Szebeni J. The interaction of liposomes with the complement system. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 57-88
10. Szebeni J., Fontana J.L., Wassef N.M., Mongan P.D., Morse D.S., Dobbins D.E., Stahl G.L., Bunger R., and Alving C.R. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99 (1999) 2302-2309
11. Szebeni J., Wassef N.M., Hartman K.R., Rudolph A.S., and Alving C.R. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 37 (1997) 150-159
12. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4 (2005) 145-160